Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1996 Mar;49(3):230–232. doi: 10.1136/jcp.49.3.230

Chronic hepatitis C in long term survivors of haematological malignancy treated in a single centre.

J R Neilson 1, P Harrison 1, S J Skidmore 1, J A King 1, K E Collingham 1, D W Milligan 1
PMCID: PMC500404  PMID: 8675735

Abstract

AIMS: To investigate the impact of hepatitis C virus (HCV) infection in long term survivors of haematological malignancy treated before the introduction of blood donor screening in September 1991. METHOD: Patients were tested for evidence of HCV infection by third generation enzyme linked immunosorbent assays, a recombinant immunoblot assay and reverse transcriptase polymerase chain reaction. Serum aspartate aminotransferase activities were measured. The number and type of blood component units received by each patient were recorded. RESULTS: Forty two patients were studied who had received a total of 7143 blood component units. Two patients (4.8%) were found to have HCV infection, both had histological evidence of chronic active hepatitis, and one is now receiving treatment with alpha-interferon. Both of these patients had been missed by the ongoing look-back programme which aims to detect recipients of all known HCV infected blood components. CONCLUSION: Although HCV infection affects a minority of long term survivors of haematological malignancy, infected patients may benefit from alpha-interferon treatment. The screening of all patients treated for haematological malignancy before September 1991 is advocated.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter H. J. Discovery of the non-A, non-B hepatitis virus: the end of the beginning or the beginning of the end. Transfus Med Rev. 1989 Apr;3(2):77–81. doi: 10.1016/s0887-7963(89)70071-7. [DOI] [PubMed] [Google Scholar]
  2. Aricò M., Maggiore G., Silini E., Bono F., Viganò C., Cerino A., Mondelli M. U. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood. 1994 Nov 1;84(9):2919–2922. [PubMed] [Google Scholar]
  3. Brink N. S., Chopra R., Perrons C. J., Ring C. J., Garson J. A., Briggs E. M., Goldstone A. H., Linch D. C., Tedder R. S. Acute hepatitis C infection in patients undergoing therapy for haematological malignancies: a clinical and virological study. Br J Haematol. 1993 Mar;83(3):498–503. doi: 10.1111/j.1365-2141.1993.tb04677.x. [DOI] [PubMed] [Google Scholar]
  4. Bruno S., Rossi S., Petroni M. L., Villa E., Zuin M., Podda M. Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. BMJ. 1994 Mar 12;308(6930):697–697. doi: 10.1136/bmj.308.6930.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ferri C., Caracciolo F., Zignego A. L., La Civita L., Monti M., Longombardo G., Lombardini F., Greco F., Capochiani E., Mazzoni A. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol. 1994 Oct;88(2):392–394. doi: 10.1111/j.1365-2141.1994.tb05036.x. [DOI] [PubMed] [Google Scholar]
  6. Garson J. A., Tuke P. W., Makris M., Briggs M., Machin S. J., Preston F. E., Tedder R. S. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates. Lancet. 1990 Oct 27;336(8722):1022–1025. doi: 10.1016/0140-6736(90)92487-3. [DOI] [PubMed] [Google Scholar]
  7. Kolho E., Oksanen K., Honkanen E., Naukkarinen R., Krusius T. Hepatitis C antibodies in dialysis patients and patients with leukaemia. J Med Virol. 1993 Aug;40(4):318–321. doi: 10.1002/jmv.1890400410. [DOI] [PubMed] [Google Scholar]
  8. Lee S. D., Hwang S. J., Lu R. H., Lai K. H., Tsai Y. T., Lo K. J. Antibodies to hepatitis C virus in prospectively followed patients with posttransfusion hepatitis. J Infect Dis. 1991 Jun;163(6):1354–1357. doi: 10.1093/infdis/163.6.1354. [DOI] [PubMed] [Google Scholar]
  9. Murphy M. F., Waters A. H., Grint P. C., Hardiman A. E., Lister T. A. Hepatitis C infection in multitransfused patients with acute leukaemia. Lancet. 1990 Jan 6;335(8680):58–59. doi: 10.1016/0140-6736(90)90194-a. [DOI] [PubMed] [Google Scholar]
  10. Mutimer D. J., Harrison R. F., O'Donnell K. B., Shaw J., Martin B. A., Atrah H., Ala F. A., Skidmore S., Hubscher S. G., Neuberger J. M. Hepatitis C in asymptomatic British blood donors with indeterminate seropositivity. BMJ. 1994 Oct 1;309(6958):847–848. doi: 10.1136/bmj.309.6958.847. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Vrielink H., van der Poel C. L., Reesink H. W., Zaaijer H. L., Scholten E., Kremer L. C., Cuypers H. T., Lelie P. N., van Oers M. H. Look-back study of infectivity of anti-HCV ELISA-positive blood components. Lancet. 1995 Jan 14;345(8942):95–96. doi: 10.1016/s0140-6736(95)90063-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES